Acute Lower gastroIntestinal BleedIng (ALIBI Study) in Italy

Completed

• Conditions: Lower GI Bleeding

• Registration Number: NCT04364412
• Lead Sponsor: Valduce Hospital

Brief Summary

Unlike upper GI bleeding, for LGIB there is still a paucity of data on clinical presentation, patient characteristics, pathways of care and outcomes for LGIB patients. In-hospital mortality ranges from 1.2% to 8.8% (2-4), according to retrospective studies, but data from prospective series are still limited (5).

Present multicentre, prospective, observational study was designed to explore these areas, to assess variations in practice management and to identify factors associated with patient outcomes.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-04-01
• Study First Submitted: 2020-04-06
• Study First Submitted QC: 2020-04-26
• Study First Posted: 2020-04-28
• Status Verified: 2020-05
• Primary Completion: 2020-05-18
• Study Completion: 2020-05-18
• Last Update Submitted: 2020-05-18
• Last Update Posted: 2020-05-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1198

Inclusion Criteria

• adult patients with acute lower GI bleeding

Exclusion Criteria

• age below 18 years
• bleeding patients with an upper GI source

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality rate in patients admitted for acute lower GI bleeding	4 weeks	Number of deaths among the study cohort

Trial Locations

Locations (1)

Valduce Hospital; 🇮🇹 Como, Italy